English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  50705005    線上人數 :  330
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"pu y s"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 506-515 / 627 (共63頁)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-05-25T02:45:33Z Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma Feng-Ming Hsu; Hou W.-H; Huang C.-Y; Wang C.-C; Tsai C.-L; Tsai Y.-C; Yu H.-J; Pu Y.-S; Cheng J.C.-H.
臺大學術典藏 2020-05-19T02:02:44Z Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis Yu-Kang Tu;Pu Y.-S.;Chien K.-L.;Yeh Y.-C.;Shih M.-C.;Tseng C.-S.;Tsai C.-Y.;Huang S.-W.; Huang S.-W.; Tsai C.-Y.; Tseng C.-S.; Shih M.-C.; Yeh Y.-C.; Chien K.-L.; Pu Y.-S.; YU-KANG TU
臺大學術典藏 2020-04-28T07:25:40Z A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer Lin C.-C.;Chih-Hung Hsu;Chen J.;Tsai T.-C.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Chen J.; Tsai T.-C.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2020-04-28T07:25:40Z Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma Chih-Hung Hsu;Chen J.;Wu C.-Y.;Cheng A.-L.;Pu Y.-S.; CHIH-HUNG HSU; Chen J.; Wu C.-Y.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2020-04-28T07:25:39Z Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y.; Lin B.-R.; Lin J.-T.; Ko J.-Y.; She T.-S.; Ho Y.-F.; CHIH-HUNG HSU; Lin J.-K.; Hsu M.-M.; Chen A.-L.; Chen A.-L.;Chih-Hung Hsu;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Pu Y.-S.;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y.
臺大學術典藏 2020-04-28T07:25:34Z Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study Lin C.-C.;Chih-Hung Hsu;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Pu Y.-S.
臺大學術典藏 2020-04-28T07:25:34Z Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏 2020-04-28T07:25:32Z Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens Pu Y.-S.;Cheng A.-L.;Huang K.-H.;Tsai Y.-C.;Huang C.-Y.;CHIH-HUNG HSU;Lin C.-C.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2020-04-28T07:25:28Z Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.; CHIH-HUNG HSU; Lin C.-C.;Chih-Hung Hsu;Cheng J.C.;Huang C.-Y.;Tsai Y.-C.;Hsu F.-M.;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.
臺大學術典藏 2020-04-28T07:25:14Z A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement Tsai Y.-C.; Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Chih-Hung Hsu;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Lin C.-C.; CHIH-HUNG HSU; Cheng A.-L.; Pu Y.-S.

顯示項目 506-515 / 627 (共63頁)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
每頁顯示[10|25|50]項目